Stanley L. Liauw

Stanley L. Liauw

Radiation Oncology
5758 S. Maryland Ave.
Chicago, IL 60637

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications

Optimizing the Therapeutic Ratio in Prostate Radiation Therapy.

Optimizing the Therapeutic Ratio in Prostate Radiation Therapy.

Journal: JAMA
Published: August 13, 2026

High-Risk Prostate Cancer Treated with Radiation Therapy: Favorable Outcomes in Men with PSA > 20 as the Sole High-Risk Factor.

High-Risk Prostate Cancer Treated with Radiation Therapy: Favorable Outcomes in Men with PSA > 20 as the Sole High-Risk Factor.

Journal: Journal of clinical medicine
Published: December 17, 2025

Resolving Clinically Indeterminate Findings During Anal Cancer Surveillance with TTMV-HPV DNA.

Resolving Clinically Indeterminate Findings During Anal Cancer Surveillance with TTMV-HPV DNA.

Journal: Cancers
Published: November 22, 2025

Pelvic MRI Following Total Neoadjuvant Therapy for Rectal Cancer Poorly Predicts a Complete Clinical Response.

Pelvic MRI Following Total Neoadjuvant Therapy for Rectal Cancer Poorly Predicts a Complete Clinical Response.

Journal: Journal of surgical oncology
Published: October 29, 2025

Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 25, 2025

Radiation Chronotherapy in Prostate Cancer: Does Time of Day of Radiation Treatment Influence Disease Outcome or Symptom Burden?

Radiation Chronotherapy in Prostate Cancer: Does Time of Day of Radiation Treatment Influence Disease Outcome or Symptom Burden?

Journal: Cancers
Published: June 25, 2025

FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate plus Prednisone and Apalutamide.

FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate plus Prednisone and Apalutamide.

Journal: European urology
Published: June 01, 2025

Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical Trial.

Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical Trial.

Journal: JAMA oncology
Published: May 15, 2025

The Evolving Management of Radiorecurrent Prostate Cancer.

The Evolving Management of Radiorecurrent Prostate Cancer.

Journal: Seminars in radiation oncology
Published: March 14, 2025

A Prospective Study of Stereotactic Body Radiation Therapy in Oligometastatic Renal Cell Carcinoma.

A Prospective Study of Stereotactic Body Radiation Therapy in Oligometastatic Renal Cell Carcinoma.

Journal: International journal of radiation oncology, biology, physics
Published: December 10, 2024

Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence.

Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence.

Journal: Cancers
Published: December 06, 2024

Genomic Classifiers To Guide Postprostatectomy Radiation Therapy: An Opening Movement in G-MINOR.

Genomic Classifiers To Guide Postprostatectomy Radiation Therapy: An Opening Movement in G-MINOR.

Journal: European urology
Published: November 11, 2024
Showing 1-12 of 118

Last Updated: 09/26/2026